CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China ##### Up next ![Valvoline™ Global Operations Celebrates Contributions of Mechanics Worldwide in Annual Appreciation Initiative](https://i0.wp.com/r2.thailandbusinessnews.net/2025/02/GBL_00002_EN_DASH_MECHANICS_MONTH_FULL_COLOR_SEAL_800.jpg?resize=200%2C110&ssl=1 "Valvoline™ Global Operations Celebrates Contributions of Mechanics Worldwide in Annual Appreciation Initiative") [](https://thailandbusinessnews.net/press-release/valvoline-global-operations-celebrates-contributions-of-mechanics-worldwide-in-annual-appreciation-initiative/) ###### [Valvoline™ Global Operations Celebrates Contributions of Mechanics Worldwide in Annual Appreciation Initiative](https://thailandbusinessnews.net/press-release/valvoline-global-operations-celebrates-contributions-of-mechanics-worldwide-in-annual-appreciation-initiative/) Published on 25 February 2025 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) ![](https://mma.prnasia.com/media2/1722549/Logo.jpg?p=medium600 "logo") SHANGHAI, Feb. 25, 2025 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK, "CARsgen Therapeutics"), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces reaching agreements with an investment fund managed by Zhuhai Hengqin SB Xinchuang Equity Investment Management Enterprise (Limited Partnership) ("Zhuhai SB Xinchuang") to jointly invest in UCARsgen Biotech Limited ("UCARsgen"), a China-based new drug discovery biotechnology company focused on allogeneic CAR-T cell therapies for the treatment of hematologic malignancies. Under the agreements, UCARsgen has secured the exclusive rights in mainland China for the research, development, manufacture, and commercialization of the following allogeneic CAR-T products from CARsgen Therapeutics: the BCMA-targeted allogeneic CAR-T cell therapy for the treatment of multiple myeloma and plasma cell leukemia and the CD19/CD20 dual-targeted allogeneic CAR-T cell therapy for the treatment of B-cell malignancies. An investment fund managed by Zhuhai SB Xinchuang (currently undergoing registration and filing procedures) subscribed to the newly increased registered capital of UCARsgen for a consideration of RMB 80,000,000, thus retaining an 8% equity stake in the registered capital of UCARsgen upon completion of the transaction, equity stake of CARsgen Therapeutics in UCARsgen will be diluted from 100% to 92%. About CARsgen Therapeutics Holdings Limited CARsgen is a biopharmaceutical company with operations in China and the U.S., focusing on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. CARsgen has established a comprehensive CAR T-cell research and development platform that covers target discovery, innovative CAR T-cell development, clinical trials, and commercial-scale production. Internally, CARsgen has developed novel technologies and a product pipeline with global rights to address significant challenges faced by existing CAR T-cell therapies. Efforts include improving safety profile, enhancing the efficacy in treating solid tumors, and reducing treatment costs. CARsgen’s mission is to become a global biopharmaceutical leader that provides innovative and differentiated cell therapies for cancer patients worldwide and makes cancer curable. Forward-looking Statements All statements in this press release that are not historical fact or that do not relate to present facts or current conditions are forward-looking statements. Such forward-looking statements express the Group’s current views, projections, beliefs and expectations with respect to future events as of the date of this press release. Such forward-looking statements are based on a number of assumptions and factors beyond the Group’s control. As a result, they are subject to significant risks and uncertainties, and actual events or results may differ materially from these forward-looking statements and the forward-looking events discussed in this press release might not occur. Such risks and uncertainties include, but are not limited to, those detailed under the heading "Principal Risks and Uncertainties" in our most recent annual report and interim report and other announcements and reports made available on our corporate website, [https://www.carsgen.com](https://www.carsgen.com/). No representation or warranty is given as to the achievement or reasonableness of, and no reliance should be placed on, any projections, targets, estimates or forecasts contained in this press release. [Source link ](https://www.prnasia.com/story/archive/4626657_CN26657_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/addx-expands-institutional-technology-solutions-with-white-label-platform/) ## ADDX Expands Institutional Technology Solutions with White-Label Platform SINGAPORE, March 5, 2026 /PRNewswire/ — ADDX, a leading digital investment platform,… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - March 5, 2026 [](https://thailandbusinessnews.net/press-release/seegenes-curecatm-emerges-as-a-potential-game-changer-in-end-to-end-pcr-automation/) ![Seegene's CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation](https://i0.wp.com/r2.thailandbusinessnews.net/2025/05/PHOTO_1.jpg?resize=260%2C140&ssl=1 "Seegene's CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Seegene's CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation Seegene previews a concept video of CURECATM at ESCMID Global 2025, ahead… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - May 2, 2025 [](https://thailandbusinessnews.net/press-release/quhuos-hotel-and-home-services-sector-partners-with-beike-to-improve-residential-service-quality/) ## Quhuo's Hotel and Home Services Sector Partners with Beike to Improve Residential Service Quality BEIJING, Sept. 30, 2025 /PRNewswire/ — Quhuo Limited (NASDAQ: QH) ("Quhuo" or… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - September 30, 2025 ##### Most Read - [![Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/priority-pass-to-accelerate-travel-innovation-backed-by-the-collinson-groups-500-million-growth-programme-2/ "Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme") [Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme](https://thailandbusinessnews.net/press-release/priority-pass-to-accelerate-travel-innovation-backed-by-the-collinson-groups-500-million-growth-programme-2/ "Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme") - [![IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/img-completes-acquisition-of-world-nomads-expanding-global-travel-insurance-distribution/ "IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution") [IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution](https://thailandbusinessnews.net/press-release/img-completes-acquisition-of-world-nomads-expanding-global-travel-insurance-distribution/ "IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution") - [![Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material](https://i0.wp.com/r2.thailandbusinessnews.net/2025/04/MODERN_MEADOW_LOGO_BLACK_PNG_Logo.jpg?fit=597%2C138&ssl=1&resize=40%2C40)](https://thailandbusinessnews.net/press-release/modern-meadow-and-bellroy-partner-on-carry-products-made-of-next-generation-material/ "Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material") [Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material](https://thailandbusinessnews.net/press-release/modern-meadow-and-bellroy-partner-on-carry-products-made-of-next-generation-material/ "Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material") - [![DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dorco-wins-2026-red-dot-award-for-renewed-corporate-identity/ "DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity") [DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity](https://thailandbusinessnews.net/press-release/dorco-wins-2026-red-dot-award-for-renewed-corporate-identity/ "DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity") - [![Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/tamarind-health-launches-rare-cancer-centre-to-make-specialist-expertise-easier-to-access/ "Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access") [Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access](https://thailandbusinessnews.net/press-release/tamarind-health-launches-rare-cancer-centre-to-make-specialist-expertise-easier-to-access/ "Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access") - [![MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/memomind-one-rolls-out-new-features-and-prepares-for-a-new-stage-of-developer-access/ "MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access") [MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access](https://thailandbusinessnews.net/press-release/memomind-one-rolls-out-new-features-and-prepares-for-a-new-stage-of-developer-access/ "MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/abogen-announces-licensing-and-option-agreement-with-novartis-to-advance-mrna-encoded-t-cell-engager-and-other-potential-rna-programs/) ## Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs Includes worldwide license to ABO2203, Abogen’s mRNA-encoded CD19xCD3 T-Cell… [](https://thailandbusinessnews.net/press-release/tech-week-singapore-2026-spotlights-the-infrastructure-powering-asias-next-digital-frontier/) ![Tech Week Singapore 2026 Spotlights the Infrastructure Powering Asia's Next Digital Frontier](https://i0.wp.com/mmx.prnasia.com/media/MS2000714/20261001070133EDT_image_3.jpg?resize=260%2C140&ssl=1 "Tech Week Singapore 2026 Spotlights the Infrastructure Powering Asia's Next Digital Frontier") ## Tech Week Singapore 2026 Spotlights the Infrastructure Powering Asia's Next Digital Frontier The two-day event brought together 38,000 attendees and 720 international exhibitors,… [](https://thailandbusinessnews.net/press-release/pci-strides-intelligent-mobility-pte-ltd-established-to-advance-smart-rail-solutions-globally-2/) ## PCI-STRIDES Intelligent Mobility Pte. Ltd. Established to Advance Smart Rail Solutions Globally SINGAPORE, Oct. 2, 2026 /PRNewswire/ — PCI Asia Technology Pte. Ltd., a… [](https://thailandbusinessnews.net/press-release/agon-unveils-oc1050hz-gaming-monitor-delivering-millisecond-fluidity/) ![AGON Unveils OC1050Hz Gaming Monitor Delivering Millisecond Fluidity](https://i0.wp.com/mmx.prnasia.com/media/MS1999452/20260923051010EDT_image_1.jpg?resize=260%2C140&ssl=1 "AGON Unveils OC1050Hz Gaming Monitor Delivering Millisecond Fluidity") ## AGON Unveils OC1050Hz Gaming Monitor Delivering Millisecond Fluidity AGP257FT combines an overclocked to 1050Hz refresh rate, 0.1ms MPRT response time,…